Market Overview

UPDATE: Morgan Stanley Lowers PT from $26 to $18 on Auxilium Pharmaceuticals


Morgan Stanley has published a report on Auxilium Pharmaceuticals (NASDAQ: AUXL) lowering the price target from $26.00 to $18.00.

In the report, Morgan Stanley wrote, " We originally saw an inflection for Xiaflex with broader physician acceptance. The June injection metrics continue to show slowing physician growth, with only ~4% of target docs earmarked as high vol. users (11+ inj) to date vs. 3% in March 2011. We still see a ~20% high vol. critical mass as a potential tipping point, but have less conviction on when we will get there."

Morgan Stanley rated Auxilium Pharmaceuticals an Equal-weight with a price target reduced from $26.00 to $18.00. Auxilium closed Monday at $17.49.

Posted-In: Auxilium Pharmaceuticals Morgan StanleyAnalyst Color Price Target Analyst Ratings


Related Articles (AUXL)

View Comments and Join the Discussion!

Latest Ratings

POWLSidoti & Co.Maintains47.0
XDeutsche BankInitiates Coverage On121.0
WTEBMO CapitalMaintains18.0
DOLBMO CapitalMaintains50.0
NABMO CapitalMaintains69.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Forex: Euro To Threaten July Rebound, U.S. Dollar Strength Ahead

Skilled Healthcare Announces Conclusion of Strategic Alternatives Exploration; Believes It is Well Positioned for the Future